Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anavip vs CroFab in Pit Viper Envenomation
NCT00868309Phase 2Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- Jan 2005
- Primary completion
- Aug 2006
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of crotalidae immune F(ab')2 (equine) in Crotalinae envenomation (2 arms), sponsored by Instituto Bioclon S.A. de C.V. Primary endpoint: Plasma Venom Levels at 2 weeks. Started Jan 2005; status: completed.
02
Drugs
crotalidae immune F(ab')2 (equine)
03
Conditions
Crotalinae envenomation
Beyond the preview
Go deeper on NCT00868309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868309.